Skip to Content

Industry Source Consulting Inc INSO

Morningstar Rating
$0.00 0.00 (2.68%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INSO is trading at a 26% discount.
Price
$0.00
Fair Value
$6.42
Uncertainty
Extreme
1-Star Price
$7.16
5-Star Price
$8.33
Economic Moat
Rxw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INSO is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.04
Bid/Ask
$0.00 / $1.01
Market Cap
$240,103.43
Volume/Avg
133 / 8,623

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Industry Source Consulting Inc is a developmental company focused on CBD product manufacturing. The company currently operates as a supplement company with brands such as N8Essentials. The Company operates with core competencies in formulation and lab testing, and by contract, manages a full-scale manufacturing certified organic 275-acre indoor and outdoor farm.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
INSO
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
INSO
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
INSO
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ADgpt$85.4 Bil
MKKGY
Merck KGaA ADRXrddqq$71.9 Bil
HLN
Haleon PLC ADRNvmd$37.8 Bil
VTRS
Viatris IncJqlyb$15.9 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRRrck$15.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRLkxb$12.8 Bil
CTLT
Catalent IncDdhxf$10.5 Bil
PRGO
Perrigo Co PLCBkll$4.4 Bil
CURLF
Curaleaf Holdings IncLzn$3.7 Bil
PBH
Prestige Consumer Healthcare IncSjcytgq$3.4 Bil

Sponsor Center